Actinomycosis is a chronic, invasive, progressive and often relapsing 55 granulomatous infection caused by Gram-positive, facultatively anaerobic rod 56 shaped bacteria belonging to the genus Actinomyces. Classical 57 Actinomycosis in humans is typically caused by Actinomyces israelii and is 58 characterized by deep invasive abscess formation, tissue fibrosis and draining 59 sinuses affecting cervicofacial, thoracic, abdominopelvic areas (1) . A number 60 of more recently described Actinomyces species and Actinomyces-like 61 organisms have been associated with less invasive superficial soft tissue 62 infections and are isolated from abscesses at various anatomical sites (2,3,4). 63
Breast infections are frequently encountered in primary care and breast 64 clinic settings. They can occur in the parenchyma of the breast or the 65 overlying skin and may be in lactating or non-lactating breasts (5). Lactating 66 breast infections are usually caused by Staphylococcus aureus (6). The 67 microbial etiology of non-lactating breast infections, particularly those which 68 are chronic or recurrent, is more variable, often polymicrobial and 69 predominantly anaerobic (5,7). A study has demonstrated that when culture 70 methods are used which enhance recovery of fastidious anaerobic organisms, 71 almost 25% of recurrent breast abscesses (8 out of 33 patients) and 10% of 72 primary breast abscesses (2 out of 19 patients) isolated Actinomyces species 73 from non-puerperal breast infections (7). However, primary Actinomyces 74 infection of the breast, first described by Ammentorp in 1893 (8), is generally 75 considered to be rare. A clinical review from 1994 reported 19 cases 76 described in the English language literature (9). Diagnosis of Actinomyces 77 breast infection was often made following surgical intervention although the 78 method of diagnosis was not specified. Duration of symptoms was reported to 79 range from 1-8 years, with two thirds of the patients presenting with recurrent 80 abscesses. The remaining third of the patients were reported to have 81 examination findings suggestive of malignancy. Most of the patients received 82 extensive surgical treatment, with 11 patients undergoing a mastectomy, 83 presumably for management of infection as only 3 were performed on patients 84 with suspected malignancy. Subsequent to this review, case reports and 85 studies have been published describing a further 27 breast infections caused 86
by Actinomyces species (table 3) . 87
Actinomyces breast infection is likely to be under ascertained in routine 88 clinical practice, as these fastidious organisms are notoriously difficult and 89 laborious to identify using conventional laboratory methods (2,3,4). 90
Subsequently there is a risk that cultures of Actinomyces species are simply 91 identified morphologically as "diphtheroids" and dismissed as skin 92 commensals, even when grown from an abscess sample. However, new 93 methods of identification such as matrix-assisted laser desorption ionization-94 time of flight mass spectrometry (MALDI-TOF MS) allow rapid and reliable 95 identification of many bacteria, including Actinomyces-like organisms 96 (10,11,12). MALDI-TOF MS and similar technologies are increasingly being 97 adopted by routine diagnostic laboratories worldwide (13). 98
We present a series describing all cases of Actinomyces species 99 isolated from breast infections at the Edinburgh Breast Unit over an 8 year 100
period from 2005-2013. Further to this we include data from Actinomyces 101 species isolated from breast samples which were referred to the Anaerobe 102
Reference Unit, Cardiff between 1988 and 2013. We then summarize the 103 applied to a target plate using a cocktail stick, allowed to dry and then 1μl of 129 100% formic acid was placed on top and allowed to dry. This mixture was 130 overlain with 1μl of matrix solution (cyano-4-hydroxycinnamic acid) and 131 allowed to dry prior to analysis using the MALDI Biotyper. Manufacturer-132 recommended cutoff scores were used for identification, with scores of >2.000 133 indicating identification to the species level, scores between 1.700 and 1.999 134 indicating identification to the genus level, and scores of <1.700 indicating no 135
identification. 136
Molecular identification. Definitive molecular identification was by 16S 137 sequencing using the following method. 16S rDNA was extracted using a 138 chelex resin/boiling method and amplified by PCR using the universal primers 139
pA & pH'. After purification (Qiaquick PCR purification kit #28106, Qiagen), a 140 second PCR reaction was performed using a primer internal to the initially 141 amplified region ('kk') and dye-terminated nucleotides (Big Dye 3.1 Terminator 142
Ready Reaction kit). After a second purification step, the sequence of bases 143 was detected by size / dye terminator of the resulting DNA fragments (ABI, 144 3100 Actinomyces species isolated from our subgroup of patients were 171
Actinomyces europaeus (n=5), A. neuii (n=3) and A. radingae (n=3). 172
Identification using MALDI-TOF MS was attempted for 11 isolates and all of 173 these correlated at species level with the definitive molecular identification, 174 with p scores ranging between 1.779 and 2.331. Co-infecting organisms were 175 present in half of these cases (n=6), usually unidentified 'anaerobes'. Ten out 176 of 12 cases (83%) had chronic, recurrent infection ranging from 2-8 (mean 177 2.8) episodes, some over many years. Three patients had hidradenitis 178 
turicensis (n=16), A. radingae (n=15) and A. odontolyticus (n=10). 240
These mostly belong to the group of Actinomyces species generally 241 considered to be less invasive, although it is noteworthy that in the Lothian 242 and UK cohorts the cases with the greatest number of relapses all isolated A. Despite finding 12 cases over 8 years at our center, which is 294 comparable to the number of cases described in the medical literature over 295 the same time period, we suspect that there were many missed 296 identifications. During the 8 year study period, we found another 15 cases in 297
Lothian where potential Actinomyces-like organisms were isolated from 298 recurrent breast abscesses, but further identification was not attempted and a 299 report was sent out describing 'diphtheroids' of doubtful or uncertain 300 significance. In addition, 4 out of our 12 culture positive cases had previous 301 samples with isolates of potential Actinomyces-like organisms reported as 302 'diphtheroids' of doubtful significance. This supports the assumption that 303 practice. Actinomyces species are slow to grow and notoriously difficult to 305 identify using conventional laboratory methods, often requiring reference 306 laboratory referral for reliable identification. When Actinomyces species do 307 grow on culture they can resemble other diphtheroid-like Gram-positive rods, 308 such as Corynebacterium species, many of which are considered to be part of 309 normal skin flora. Actinomyces species which are isolated from breast 310 abscess samples may therefore be presumptively identified in the laboratory 311 as 'diphtheroids' based on their morphology and reported as 'diphtheroids' of 312 doubtful or uncertain significance. However, laboratories are increasingly 313 adopting new methods of identification, such as MALDI-TOF MS (13), which 314 allow rapid and increasingly reliable identification of this problematic group of 315 organisms (10,11,12). Indeed, most of the cases in Lothian were identified 316 after 2012, which is shortly after our laboratory started using MALDI-TOF MS. 317
With 10 cases diagnosed in 2 years of using MALDI-TOF MS compared to 2 318 cases over 7 years without MALDI-TOF MS, it is clear that ease of 319 identification is a major factor in the increased recognition of Actinomyces 320 breast infections in our clinical setting. The Anaerobe Reference Unit (ARU) 321 has seen a similar increase in the number of isolates referred to them, with 322 more isolates (n=26) referred to them over the last 3 years of the recorded 323 period than had been referred over the first 20 years (n=25). Based on 324 information from referring laboratories, this increase is almost certainly driven 325 by an improvement in the identification of Actinomyces species due to 326 increased use of MALDI-TOF MS. Subsequently, UK laboratories unfamiliar 327 susceptibility testing and clinical advice. 329
Our results support previous findings that Actinomyces species can be 330 reliably identified using MALDI-TOF MS (10,11,12), with all 12 of our tested 331 isolates identified to species level, as confirmed by molecular testing. Five 332 isolates were correctly identified to species level by MALDI-TOF MS despite 333 identification scores only reaching genus level confidence (p<2.0). This is in 334 keeping with recent evidence suggesting that the cut-off for species level 335 identification could be reassessed and perhaps lowered to p>=1.7 for this 336 group of organisms (10,12). 337
We have modified the approach to how organisms from breast samples 338 are identified in Lothian. Breast abscess samples now receive anaerobic 339 incubation for 5 days, along with prolonged Actinomyces cultures when 340 clinical details mention chronic or recurring infection. Any Gram-positive 341 bacillus growing from a breast abscess sample is identified using MALDI-TOF 342 MS and should no longer be reported as a "diphtheroid" of uncertain 343 significance without an attempt being made to identify the organism. 344
The primary management of breast abscess is drainage, along with 345 antibiotic therapy appropriate for the underlying cause of the abscess (31). Table 4 . Combined number and species of Actinomyces breast infections from tables 1-3 and from reference 7.
